Degradation of Ikaros and Aiolos by lenalidomide and pomalidomide leads to specific and sequential downregulation of c-Myc followed by interferon regulatory factor 4 (IRF4), which results in subsequent cell death of myeloma cells (189). The gene discussed is IRF4; the disease is plasma cell myeloma.